Home
About Us
Services
Transactions
Raising Spirits
Opportunities
Genomics
Contact Us

Home
About Us
Services
Transactions
Raising Spirits
Opportunities
Genomics
Contact Us

Scott Jordan

7 New Blockbuster Drugs to Watch in 2016

3 minute read

Read More

Venture Capital

The Top 10 Venture Capital Investors In The World: Midas List 2016

4 minute read

Read More

M&A

Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M

3 minute read

Read More

Venture Capital

Funding for Early-Stage Biopharma Dwindled in 2015

3 minute read

Read More

Software Is Disrupting Venture-Capital Sector

3 minute read

Read More

Bacteria or Virus? New Tests May Identify What’s Causing Your Infection

4 minute read

Read More

M&A

IBM to Buy Truven Health Analytics for $2.6 Billion

1 minute read

Read More

Healthcare Information Technology

New Online Tools Offer Path to Lower Drug Prices

4 minute read

Read More

Why Biotech's Biggest Breakthrough Is Now In Dispute

3 minute read

Read More

IPO Market Comes to a Standstill

4 minute read

Read More

Prev 2 3 4 5 6 Next

Securities are offered through Finalis Securities LLC Member FINRA/SIPC. S. Jordan Associates and Finalis Securities LLC are separate, unaffiliated entities. www.sjordanassociates.com (the "S. Jordan Associates Website") is a website operated by S. Jordan Associates, a privately held Illinois limited liability company. S. Jordan Associates provides e.g., financial and strategic advisory, consulting services, mergers and acquisitions services, fairness opinions, etc.

The Business Continuity Plan and Privacy Policy of Finalis, contained on www.finalis.com • FINRA Broker Check — www.finalis.com.